Clinical Trial Update: Wharton's Jelly-derived Mesenchymal Stem Cells in Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating Wharton's Jelly-derived mesenchymal stem cells for osteoarthritis of the hip, knee, and shoulder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glenohumeral Osteoarthritis
• Hip Osteoarthritis
• Knee Osteoarthritis
• Osteoarthritis

Drugs mentioned

• Wharton's Jelly Derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Osteoarthritis, Hip Osteoarthritis | Phase 1, Phase 2 | Status: UNKNOWN